King’s College London and Pioneer Group in incubator link-up
Collaboration aims to revitalise two empty sites on the South Bank of London by providing several laboratories
Read More
Tag: PIONEER
UK launch for Novo’s new diabetes pill
Rybelsus is the world’s first and only oral GLP-1 receptor agonist
Read More
PIONEER COVID-19 trial wins funding injection from LifeArc
The funds will enable researchers to investigate the science around the trial, including why coronavirus affects some people more than others
Read More
Oral semaglutide trumps Jardiance, Januvia, Victoza in type II diabetes
Type II diabetes costs the NHS £8.8 billion a year.
Read More
